» Articles » PMID: 19482605

Settings and Mechanisms for Trans-cellular Diapedesis

Overview
Specialty Biology
Date 2009 Jun 2
PMID 19482605
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Immune system functions require blood leukocytes to continuously traffic throughout the body and repeatedly cross endothelial barriers (i.e., diapedese) as they enter (intravasation) and exit (extravasation) the circulation. The earliest studies to directly characterize diapedesis in vivo suggested co-existence of two distinct migratory pathways: between (para-cellular) and through (trans-cellular) individual endothelial cells. However, in the absence of conclusive in vitro observations, the latter pathway remained poorly accepted. The recent emergence of unambiguous in vitro reports of trans-cellular diapedesis has begun to illuminate mechanisms for this pathway and has renewed interest in its physiological roles. A thorough reevaluation of the existing literature reveals a large number of studies documenting significant use of the trans-cellular pathway in diverse in vivo settings. These include constitutive trafficking in bone marrow and lymphoid organs as well as upregulated extravasation in peripheral tissues during inflammation. Here we collectively summarize these in vivo observations alongside the emerging in vitro data in order to provide a framework for understanding the settings, mechanisms and roles for the trans-cellular route of diapedesis.

Citing Articles

Neutrophil Extracellular DNA Traps in Response to Infection or Inflammation, and the Roles of Platelet Interactions.

Chen W, Boskovic D Int J Mol Sci. 2024; 25(5).

PMID: 38474270 PMC: 10932463. DOI: 10.3390/ijms25053025.


Blood-brain barrier dysfunction in intensive care unit.

Le Guennec L, Weiss N J Intensive Med. 2023; 3(4):303-312.

PMID: 38028637 PMC: 10658046. DOI: 10.1016/j.jointm.2023.01.001.


Endocanalicular transendothelial crossing (ETC): A novel intravasation mode used by HEK-EBNA293-VEGF-D cells during the metastatic process in a xenograft model.

Armando F, Ferrari L, Arcari M, Azzali G, Dallatana D, Ferrari M PLoS One. 2020; 15(10):e0239932.

PMID: 33085676 PMC: 7577447. DOI: 10.1371/journal.pone.0239932.


Targeting Chemokine-Glycosaminoglycan Interactions to Inhibit Inflammation.

Crijns H, Vanheule V, Proost P Front Immunol. 2020; 11:483.

PMID: 32296423 PMC: 7138053. DOI: 10.3389/fimmu.2020.00483.


Neutrophil transendothelial migration: updates and new perspectives.

Filippi M Blood. 2019; 133(20):2149-2158.

PMID: 30898863 PMC: 6524565. DOI: 10.1182/blood-2018-12-844605.


References
1.
Middleton J, Patterson A, Gardner L, Schmutz C, Ashton B . Leukocyte extravasation: chemokine transport and presentation by the endothelium. Blood. 2002; 100(12):3853-60. DOI: 10.1182/blood.V100.12.3853. View

2.
Rodrigo Mora J, von Andrian U . T-cell homing specificity and plasticity: new concepts and future challenges. Trends Immunol. 2006; 27(5):235-43. DOI: 10.1016/j.it.2006.03.007. View

3.
Burns A, Smith C, Walker D . Unique structural features that influence neutrophil emigration into the lung. Physiol Rev. 2003; 83(2):309-36. DOI: 10.1152/physrev.00023.2002. View

4.
BARRON K, MEANS E, Feng T, Harris H . Ultrastructure of retrograde degeneration in thalamus of rat. 2. Changes in vascular elements and transvascular migration of leukocytes. Exp Mol Pathol. 1974; 20(3):344-62. DOI: 10.1016/0014-4800(74)90065-3. View

5.
Wolosewick J . Distribution of actin in migrating leukocytes in vivo. Cell Tissue Res. 1984; 236(3):517-25. DOI: 10.1007/BF00217218. View